NFKB1 and myeloid sarcoma: In addition, NF-κB signaling is overactive in MS patients and functional studies have shown that NF-κB pathway SNPs rs228614, rs228614 and rs1800693 can alter NF-κB component expression and lead to increased NF-κB activity and inflammatory cytokine production (44).